braf mutated melanoma: targeted or immunotherapy?
Published 6 years ago • 1.2K plays • Length 2:29Download video MP4
Download video MP3
Similar videos
-
2:58
role of braf mutation in the treatment for melanoma
-
7:15
dual targeted or immunotherapy for braf-mutant melanoma
-
1:17
treatment selection for stage iii braf-mutant melanoma
-
3:08
os rates and prognostic categories for braf-mutated melanoma when treated with combination therapy
-
9:24
anti-pd1 monotherapy or combination with ipi after braf/mek inhibitors in braf-mutant melanoma
-
2:40
neoadjuvant targeted therapy in braf v600 mutated melanoma
-
4:05
vemurafenib and cobimetinib in patients with braf-mutated melanoma
-
1:48
secombit – determining the order of sequential therapies in metastatic melanoma with braf mutations
-
1:54
targeted therapies in melanoma
-
0:59
the success of the dabrafenib and trametinib combination in braf-mutated melanoma
-
5:40
immunotherapy and targeted therapies for melanoma
-
1:23
braf in melanoma explained
-
20:35
hitting the mark with targeted therapy: braf, nras, ckit, etc...sullivan
-
1:01:29
new rules for sequential care in braf-mutated melanoma
-
7:31
case 2: braf-mutated metastatic melanoma
-
2:10
using biomarkers to predict response to combination therapies in braf-mutant melanoma
-
5:31
treating braf-mutated metastatic melanoma
-
4:18
development of novel treatments in melanoma patients with braf mutations
-
27:28
advances in therapy for braf-mutant melanoma